# MDA and Targeted Control Against Plasmodium Carriage in the Sahel

> **NCT07281443** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut de Recherche pour le Developpement** · enrollment: 18000 (estimated)

## Conditions studied

- Malaria, Falciparum
- Malaria, Asymptomatic Parasitaemia

## Interventions

- **DRUG:** MDA with DHAp and SLD Primaquine
- **BEHAVIORAL:** Targeted control (10-24 years) during the malaria high tranmission season: behaviour
- **DIAGNOSTIC_TEST:** Targeted control (15-24 years) during the malaria high tranmission season: test and treat

## Key facts

- **NCT ID:** NCT07281443
- **Lead sponsor:** Institut de Recherche pour le Developpement
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-23
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 18000 (ESTIMATED)
- **Last updated:** 2025-12-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07281443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07281443, "MDA and Targeted Control Against Plasmodium Carriage in the Sahel". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07281443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*